Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Orthobiologics Market: By Product Type,BMP, PRP, and BAMC, By Application, By End User, and Region Forecast 2019-2030
Orthobiologics Market: By Product Type,BMP, PRP, and BAMC, By Application, By End User, and Region Forecast 2019-2030
Orthobiologics market size was valued at $5261.38 million in 2023 and is projected to reach $7208.11 million by 2030, registering a CAGR of 4.6% from 2024 to 2030. Orthobiologics are biological substances that are used to help injuries to heal more quickly. Orthobiologics are used to improve the healing of injured muscles, fractures, tendons, and ligaments. Orthobiologics are made from substances that occur naturally in the body. When they are used in more amounts, they may help to increase the healing process. When a tissue is injured bleeding occurs, after bleeding matrix, stem cells and growth factors play an important role in tissue healing and they are natural orthobiologics in human body. Matrix serves as building blocks that help to fill tissue gaps. Growth factors act on stem cells to cause the repair of the injured tissue.
The rise in the global geriatric population, which is more susceptible to diseases like osteoarthritis and others, is fueling the expansion of the market. Other factors projected to drive market growth include increased awareness of orthobiologics and increased demand for improved therapy. Furthermore, during the projected period, strong development potential in developing countries and an increase in demand for sophisticated treatment are expected to generate new possibilities for market competitors. However, the market's expansion is hampered by the greater cost of orthobiologics and the lengthy approval process.Because of the rising prevalence of OA, a better understanding of the disease pathophysiology, improved early detection, disease prevention strategies, and early management are all urgently needed. Orthobiologics may be one such treatment option for OA.
Study Period
2024-2030Base Year
2023CAGR
4.6%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Sports related injuries are common among professional and recreational athletes are increasingly encountered and diagnosed. They demand quick healing so that they can return to their normal sporting activities. Hence, orthobiologics is gaining more preference from various physicians. Bone grafts act by their osteoinductive, osteoconductive and osteogenic properties to stimulate new bone formation and have no effect on the healing of muscles, tendons and ligaments.
On the other hand, autologous blood, PRP and autologous conditioned serum deliver growth factors to the diseased areas to stimulate the repair process. These biologic substances have their own advantages and some disadvantages also. Lack of clinical data and cost-intensive products are restrain the growth of the market. On the other hand, the high cost associated with orthobiologics-based treatments is the major factor restraining the growth of the orthobiologics market.
North America is expected to command the largest share of the market in 2017 due to an increase in incidence of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and growing physician and patient awareness about newly introduced treatment procedures and technologies. However, Asia Pacific is expected to register the highest growth rate during the forecast period. The presence of a large geriatric and target patient population, high incidence of osteoarthritis and obesity, increase in government spending on healthcare, and improving healthcare infrastructure are some of the major factors driving the growth of the Asia Pacific market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
4.6% |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global orthobiologics market size was valued at US$ 5261.38 million in 2023 and is projected to grow at a CAGR of 4.6% from 2024 to 2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
The orthobiologics market key players are: Medtronic, NuVasive Inc., Stryker Corporation, Zimmer Biomet, Orthofix International, RTI Surgical Inc., Kuros Biosciences Ltd, Bioventus LLC, DePuy Synthes (Johnson and Johnson), Arthrex, SeaSpine Holdings Corporation
| 1.Executive Summary |
| 2.Global Orthobiologics Market Introduction |
| 2.1.Global Orthobiologics Market - Taxonomy |
| 2.2.Global Orthobiologics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Orthobiologics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Orthobiologics Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Orthobiologics Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Viscosupplementation Products |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Allografts |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Synthetic Orthobiologics |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. DBM |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. BMP |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. PRP |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.8. BAMC |
| 5.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6.Global Orthobiologics Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Osteoarthritis |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Degenerative Arthritis |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Spinal Fusion |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Fracture Recovery |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Soft Tissue Injuries, |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Maxillofacial and Dental Applications |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Orthobiologics Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research and Academic Institutes |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Dental Clinics and Facilities |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Orthobiologics Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Orthobiologics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Viscosupplementation Products |
| 9.1.2.Allografts |
| 9.1.3.Synthetic Orthobiologics |
| 9.1.4.DBM |
| 9.1.5.BMP |
| 9.1.6.PRP |
| 9.1.7.BAMC |
| 9.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Osteoarthritis |
| 9.2.2.Degenerative Arthritis |
| 9.2.3.Spinal Fusion |
| 9.2.4.Fracture Recovery |
| 9.2.5.Soft Tissue Injuries, |
| 9.2.6.Maxillofacial and Dental Applications |
| 9.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Research and Academic Institutes |
| 9.3.3.Dental Clinics and Facilities |
| 9.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Orthobiologics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Viscosupplementation Products |
| 10.1.2.Allografts |
| 10.1.3.Synthetic Orthobiologics |
| 10.1.4.DBM |
| 10.1.5.BMP |
| 10.1.6.PRP |
| 10.1.7.BAMC |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Osteoarthritis |
| 10.2.2.Degenerative Arthritis |
| 10.2.3.Spinal Fusion |
| 10.2.4.Fracture Recovery |
| 10.2.5.Soft Tissue Injuries, |
| 10.2.6.Maxillofacial and Dental Applications |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Research and Academic Institutes |
| 10.3.3.Dental Clinics and Facilities |
| 10.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Orthobiologics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Viscosupplementation Products |
| 11.1.2.Allografts |
| 11.1.3.Synthetic Orthobiologics |
| 11.1.4.DBM |
| 11.1.5.BMP |
| 11.1.6.PRP |
| 11.1.7.BAMC |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Osteoarthritis |
| 11.2.2.Degenerative Arthritis |
| 11.2.3.Spinal Fusion |
| 11.2.4.Fracture Recovery |
| 11.2.5.Soft Tissue Injuries, |
| 11.2.6.Maxillofacial and Dental Applications |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Research and Academic Institutes |
| 11.3.3.Dental Clinics and Facilities |
| 11.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Orthobiologics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Viscosupplementation Products |
| 12.1.2.Allografts |
| 12.1.3.Synthetic Orthobiologics |
| 12.1.4.DBM |
| 12.1.5.BMP |
| 12.1.6.PRP |
| 12.1.7.BAMC |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Osteoarthritis |
| 12.2.2.Degenerative Arthritis |
| 12.2.3.Spinal Fusion |
| 12.2.4.Fracture Recovery |
| 12.2.5.Soft Tissue Injuries, |
| 12.2.6.Maxillofacial and Dental Applications |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Research and Academic Institutes |
| 12.3.3.Dental Clinics and Facilities |
| 12.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Orthobiologics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Viscosupplementation Products |
| 13.1.2.Allografts |
| 13.1.3.Synthetic Orthobiologics |
| 13.1.4.DBM |
| 13.1.5.BMP |
| 13.1.6.PRP |
| 13.1.7.BAMC |
| 13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Osteoarthritis |
| 13.2.2.Degenerative Arthritis |
| 13.2.3.Spinal Fusion |
| 13.2.4.Fracture Recovery |
| 13.2.5.Soft Tissue Injuries, |
| 13.2.6.Maxillofacial and Dental Applications |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Research and Academic Institutes |
| 13.3.3.Dental Clinics and Facilities |
| 13.4. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Medtronic |
| 14.2.2.NuVasive Inc. |
| 14.2.3.Stryker Corporation |
| 14.2.4.Zimmer Biomet |
| 14.2.5.Orthofix International |
| 14.2.6.RTI Surgical Inc., |
| 14.2.7.Kuros Biosciences Ltd |
| 14.2.8.Bioventus LLC |
| 14.2.9.DePuy Synthes (Johnson and Johnson) |
| 14.2.10.Arthrex |
| 14.2.11.SeaSpine Holdings Corporation |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.